Skip to main content

SPRO

Stock
Health Care
Biotechnology

Performance overview

SPRO Price
Price Chart

Forward-looking statistics

Beta
0.92
Risk
52.99%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.

Company info

SectorHealth Care
IndustryBiotechnology
Employees67
Market cap$75.9M

Fundamentals

Enterprise value—
Revenue—
Revenue per employee—
Profit margin—
Debt to equity—

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)—
Avg trading volume (10 day)—
Put-call ratio—

Macro factor sensitivity

Growth+8.2
Credit+1.2
Liquidity-4.3
Inflation+5.3
Commodities+0.2
Interest Rates+0.1

Valuation

Dividend yield0.00%
PEG Ratio—
Price to sales—
P/E Ratio-0.50
Enterprise Value to Revenue—
Price to book—

Upcoming events

Next earnings dayMay 14, 2025
Next dividend day—
Ex. dividend day—

News

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

SPRO shares surge after GSK-partnered oral drug hits phase III goal early, paving the way for FDA filing and a shift in cUTI treatment options.

Zacks Investment Research (May 29, 2025)
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?

GSK plc GSK and Spero Therapeutics Inc SPRO on Wednesday announced that the pivotal phase 3 PIVOT-PO trial evaluating tebipenem HBr for complicated urinary tract infections (cUTIs) will stop early for efficacy.

Benzinga (May 28, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free